|
Market Closed -
Nasdaq
04:00:00 2026-04-16 pm EDT
|
5-day change
|
1st Jan Change
|
|
746.00 USD
|
-1.05%
|
 |
-2.85%
|
-3.35%
|
|
Feb. 19 |
AtaiBeckley Inc. Announces Executive Changes, Effective March 9, 2026
|
CI
| |
Feb. 11 |
Regeneron Pharmaceuticals Insider Sold Shares Worth $1,585,058, According to a Recent SEC Filing
|
MT
| |
Jan. 21 |
Ocular Therapeutix, Inc. Appoints David W. Robinson As Global Chief Commercial Officer
|
CI
| |
Jan. 13 |
Regeneron's Yancopoulos on Hearing Loss Gene Therapy, Weight Loss Drugs
|
MT
| |
Jan. 08 |
Regeneron Pharmaceuticals Insider Sold Shares Worth $1,200,000, According to a Recent SEC Filing
|
MT
| |
Jan. 08 |
Anavex Life Sciences Corp Appoints Dr. Wolfgang Liedtke as Senior Vice President, Global Head of Neurology
|
CI
| |
25-10-31 |
Regeneron Pharmaceuticals Insider Sold Shares Worth $4,252,745, According to a Recent SEC Filing
|
MT
| |
25-05-20 |
PRESS DIGEST-Wall Street Journal - May 20
|
RE
| |
25-04-28 |
Arrivent Biopharma Inc Appoints Merdad Parsey to Its Board of Directors
|
CI
| |
25-01-14 |
Regeneron CSO Yancopoulos on Weight-Loss Drugs, Pipeline
|
MT
| |
24-11-05 |
Regeneron Pharmaceuticals Insider Sold Shares Worth $844,610, According to a Recent SEC Filing
|
MT
| |
24-10-03 |
Regeneron Pharmaceuticals Insider Sold Shares Worth $1,054,060, According to a Recent SEC Filing
|
MT
| |
24-09-05 |
Regeneron Pharmaceuticals Insider Sold Shares Worth $1,178,730, According to a Recent SEC Filing
|
MT
| |
24-08-29 |
Regeneron Pharmaceuticals Insider Sold Shares Worth $6,846,262, According to a Recent SEC Filing
|
MT
| |
24-08-19 |
Regeneron Pharmaceuticals Insider Sold Shares Worth $12,552,285, According to a Recent SEC Filing
|
MT
| |
24-08-19 |
Regeneron Pharmaceuticals Insider Sold Shares Worth $884,520, According to a Recent SEC Filing
|
MT
| |
24-08-15 |
Regeneron Pharmaceuticals Insider Sold Shares Worth $7,337,505, According to a Recent SEC Filing
|
MT
| |
24-07-23 |
BridgeBio Pharma, Inc. Announces Executive Changes
|
CI
| |
24-07-02 |
Regeneron Pharmaceuticals Insider Sold Shares Worth $1,190,564, According to a Recent SEC Filing
|
MT
| |
24-06-17 |
Regeneron Pharmaceuticals Insider Sold Shares Worth $1,596,400, According to a Recent SEC Filing
|
MT
| |
24-06-13 |
Regeneron Pharmaceuticals Insider Sold Shares Worth $25,610,229, According to a Recent SEC Filing
|
MT
| |
24-06-10 |
Regeneron Pharmaceuticals Insider Sold Shares Worth $798,821, According to a Recent SEC Filing
|
MT
| |
24-06-05 |
Regeneron Pharmaceuticals Insider Sold Shares Worth $1,115,422, According to a Recent SEC Filing
|
MT
| |
24-05-29 |
Regeneron Pharmaceuticals Insider Sold Shares Worth $1,142,536, According to a Recent SEC Filing
|
MT
| |
24-05-22 |
Regeneron Pharmaceuticals Insider Sold Shares Worth $1,855,489, According to a Recent SEC Filing
|
MT
|
No results for this search Select your edition All financial news and data tailored to specific country editions | 
